<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0006311"><a href="http://purl.obolibrary.org/obo/MONDO_0006311">MONDO:0006311</a></h3>
<p><strong>Label:</strong> myelodysplastic/myeloproliferative neoplasm</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0011996">MONDO:0011996</a> (chronic myelogenous leukemia), <a href="http://purl.obolibrary.org/obo/MONDO_0020312">MONDO:0020312</a> (atypical chronic myeloid leukemia),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://purl.obolibrary.org/obo/OMIM_608232">OMIM:608232</a>, <a href="http://www.orpha.net/ORDO/Orphanet_521">Orphanet:521</a>, <a href="http://www.orpha.net/ORDO/Orphanet_98824">Orphanet:98824</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0004848">HP:0004848</a> (Ph-positive acute lymphoblastic leukemia) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001912">HP:0001912</a> (Abnormality of basophils) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0005558">HP:0005558</a> (Chronic leukemia) and <a href="http://purl.obolibrary.org/obo/HP_0006721">HP:0006721</a> (Acute lymphoblastic leukemia) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0005506">HP:0005506</a> (Chronic myelogenous leukemia) and <a href="http://purl.obolibrary.org/obo/HP_0006721">HP:0006721</a> (Acute lymphoblastic leukemia) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0004848">HP:0004848</a> (Ph-positive acute lymphoblastic leukemia) and <a href="http://purl.obolibrary.org/obo/HP_0005558">HP:0005558</a> (Chronic leukemia) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0004848">HP:0004848</a> (Ph-positive acute lymphoblastic leukemia) and <a href="http://purl.obolibrary.org/obo/HP_0005506">HP:0005506</a> (Chronic myelogenous leukemia) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001428">HP:0001428</a> (Somatic mutation) and <a href="http://purl.obolibrary.org/obo/HP_0006721">HP:0006721</a> (Acute lymphoblastic leukemia) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001428">HP:0001428</a> (Somatic mutation) and <a href="http://purl.obolibrary.org/obo/HP_0005506">HP:0005506</a> (Chronic myelogenous leukemia) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001428">HP:0001428</a> (Somatic mutation) and <a href="http://purl.obolibrary.org/obo/HP_0004848">HP:0004848</a> (Ph-positive acute lymphoblastic leukemia) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000005">HP:0000005</a> (Mode of inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0005506">HP:0005506</a> (Chronic myelogenous leukemia) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000005">HP:0000005</a> (Mode of inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0004848">HP:0004848</a> (Ph-positive acute lymphoblastic leukemia) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0005506">HP:0005506</a> (Chronic myelogenous leukemia) and (not (<a href="http://purl.obolibrary.org/obo/HP_0100545">HP:0100545</a> (Arterial stenosis))) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0005506">HP:0005506</a> (Chronic myelogenous leukemia) and (not (<a href="http://purl.obolibrary.org/obo/HP_0030680">HP:0030680</a> (Abnormality of cardiovascular system morphology))) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0005506">HP:0005506</a> (Chronic myelogenous leukemia) and (not (<a href="http://purl.obolibrary.org/obo/HP_0025015">HP:0025015</a> (Abnormal vascular morphology))) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0005506">HP:0005506</a> (Chronic myelogenous leukemia) and (not (<a href="http://purl.obolibrary.org/obo/HP_0012639">HP:0012639</a> (Abnormality of nervous system morphology))) 66.67%</li>
</ul>
</body>
</html>
